Gfs Advisors, LLC Merck & Co., Inc. Transaction History

Gfs Advisors, LLC

$728 Million
Q2 2025

A detailed history of Gfs Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Gfs Advisors, LLC holds 131,814 shares of MRK stock, worth $11.5 Million. This represents 1.43% of its overall portfolio holdings.

Number of Shares

131,814

Previous 82,374 60.02%

Holding current value

$11.5 Million

Previous $7.39 Million 41.13%

% of portfolio

1.43%

Previous 1.49%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Jul 25, 2025	BUY	$73.47 - $87.12 $3.63 Million - $4.31 Million	49,440 Added 60.02%	131,814 $10.4 Million
Q1 2025 Apr 21, 2025	SELL	$83.01 - $101.02 $15,522 - $18,890	-187 Reduced 0.23%	82,374 $7.39 Million
Q4 2024 Jan 23, 2025	BUY	$96.31 - $114.76 $161,319 - $192,223	1,675 Added 2.07%	82,561 $8.21 Million
Q3 2024 Oct 29, 2024	BUY	$111.15 - $128.97 $8.88 Million - $10.3 Million	79,926 Added 8325.63%	80,886 $9.19 Million
Q2 2024 Jul 26, 2024	SELL	$123.8 - $132.96 $10 Million - $10.8 Million	-80,984 Reduced 98.83%	960 $118,000
Q1 2024 Apr 25, 2024	SELL	$113.24 - $131.95 $168,274 - $196,077	-1,486 Reduced 1.78%	81,944 $10.8 Million
Q4 2023 Jan 24, 2024	BUY	$100.18 - $109.02 $36,866 - $40,119	368 Added 0.44%	83,430 $9.1 Million
Q3 2023 Oct 19, 2023	BUY	$102.95 - $114.33 $2.55 Million - $2.84 Million	24,801 Added 42.57%	83,062 $8.55 Million
Q1 2023 Apr 27, 2023	SELL	$102.94 - $114.86 $308,820 - $344,580	-3,000 Reduced 4.9%	58,261 $6.2 Million
Q4 2022 Jan 26, 2023	SELL	$87.44 - $112.11 $34,101 - $43,722	-390 Reduced 0.63%	61,261 $0
Q3 2022 Oct 13, 2022	SELL	$84.53 - $94.96 $66,102 - $74,258	-782 Reduced 1.25%	61,651 $5.31 Million
Q2 2022 Jul 19, 2022	SELL	$83.49 - $94.64 $5.79 Million - $6.56 Million	-69,347 Reduced 52.62%	62,433 $5.69 Million
Q1 2022 Apr 21, 2022	SELL	$73.51 - $82.4 $2.1 Million - $2.35 Million	-28,500 Reduced 17.78%	131,780 $10.8 Million
Q4 2021 Jan 21, 2022	BUY	$72.28 - $90.54 $3.06 Million - $3.83 Million	42,315 Added 35.87%	160,280 $12.3 Million
Q3 2021 Nov 03, 2021	BUY	$71.68 - $78.83 $484,198 - $532,496	6,755 Added 6.07%	117,965 $8.86 Million
Q2 2021 Jul 26, 2021	BUY	$70.31 - $77.77 $271,748 - $300,581	3,865 Added 3.6%	111,210 $8.65 Million
Q1 2021 May 03, 2021	SELL	$68.86 - $81.11 $203,137 - $239,274	-2,950 Reduced 2.67%	107,345 $8.28 Million
Q4 2020 Feb 02, 2021	BUY	$71.77 - $79.65 $15,789 - $17,523	220 Added 0.2%	110,295 $9.02 Million
Q3 2020 Nov 12, 2020	BUY	$73.18 - $82.95 $1.07 Million - $1.22 Million	14,655 Added 15.36%	110,075 $9.13 Million
Q2 2020 Jul 29, 2020	BUY	$70.42 - $80.13 $4.05 Million - $4.61 Million	57,571 Added 152.11%	95,420 $7.38 Million
Q1 2020 May 05, 2020	BUY	$63.36 - $87.82 $895,910 - $1.24 Million	14,140 Added 59.64%	37,849 $2.91 Million
Q3 2019 Oct 31, 2019	BUY	$76.08 - $82.93 $19,780 - $21,561	260 Added 1.11%	23,709 $2 Million
Q1 2019 May 13, 2019	BUY	$69.58 - $79.36 $1.63 Million - $1.86 Million	23,449 New	23,449 $1.95 Million
Q4 2018 Feb 12, 2019	SELL	$65.24 - $75.71 $13,047 - $15,141	-200 Reduced 0.85%	23,449 $1.79 Million
Q3 2018 Nov 27, 2018	SELL	$57.69 - $67.84 $1.9 Million - $2.24 Million	-33,020 Reduced 58.27%	23,649 $1.68 Million
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $2.46 Million - $2.89 Million	-42,600 Reduced 42.91%	56,669 $4.02 Million
Q2 2018 Aug 08, 2018	BUY	$50.83 - $59.72 $52,100 - $61,213	1,025 Added 1.04%	99,269 $6.03 Million
Q1 2018 May 09, 2018	BUY	$50.96 - $59.23 $121,947 - $141,737	2,393 Added 2.5%	98,244 $5.35 Million
Q4 2017 Feb 09, 2018	SELL	$51.62 - $61.64 $2.83 Million - $3.37 Million	-54,739 Closed	0 $0
Q3 2017 Nov 07, 2017	SELL	$58.67 - $63.13 $8,859 - $9,532	-151 Reduced 0.28%	54,739 $3.51 Million
Q2 2017 Aug 07, 2017	BUY	N/A	54,890	54,890 $3.52 Million

Others Institutions Holding MRK

# of Institutions

3,842

Shares Held

1.96B

Call Options Held

29.2M

Put Options Held

30M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $222B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gfs Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gfs Advisors, LLC with notifications on news.

Account